Study of neutrophil/lymphocyte and platelet/lymphocyte ratios in type 2 diabetes mellitus

Isabella Junqueira Martins; Isabela Cinquini Junqueira; Thais Cardoso do Nascimento; Sérgio Henrique Nascente Costa; Keila Correia de  Alcântara

doi:10.14393/BJ-v40n0a2024-67412

Autores

Isabella Junqueira Martins Universidade Federal de Goiás https://orcid.org/0000-0001-8985-2311
Isabela Cinquini Junqueira Universidade Federal de Goiás
Thais Cardoso do Nascimento Brazilian https://orcid.org/0000-0002-5702-8587
Sérgio Henrique Nascente Costa Universidade Federal de Goiás https://orcid.org/0000-0002-4225-6368
Keila Correia de Alcântara Universidade Federal de Goiás https://orcid.org/0000-0002-4477-2833

DOI:

https://doi.org/10.14393/BJ-v40n0a2024-67412

Palavras-chave:

Chronic Disease, Comorbidity, Diabetes mellitus, Health planning, Severity of illness index.

Resumo

The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are potential inflammatory biomarkers for prognostic analysis in several diseases, such as type 2 diabetes mellitus (T2DM). This study analyzed NLR and PLR as possible T2DM biomarkers. A cross-sectional study was conducted with a secondary database that included laboratory test results from two healthcare units in Goiânia, GO, Brazil, between 2015 and 2016. The participants were normoglycemic (NG), prediabetic (preDM), and had controlled DM (CDM) and uncontrolled DM (UDM). NLR and PLR were compared between study groups according to sex and age group. NLR was higher in group UDM than preDM (1.88 vs. 1.62, p <0.05) and lower in group preDM than NG (1.62 vs. 1.80, p <0.05). NG women aged ≥65 years were six times more likely to present PLR ≤91.83 than preDM ones (OR: 6.34; CI: 1.98 - 20.55; sensitivity = 41.5%, PPV = 84.6, and LR + = 4.15). NG men aged <65 years were almost four times more likely to present PLR ≤120 (OR: 3.64; CI: 1.21 - 10.89; sensitivity = 80%, PPV = 37.7, and LR + 1.53) than preDM ones. NLR and PLR increases are directly proportional to DM severity, except for group preDM compared to NG for NLR values. These biomarkers can help estimate T2DM prognosis.

Downloads

Não há dados estatísticos.

Referências

ACMAZ, G., et al. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pacific Journal of Cancer Prevention. 2014, 15(4), 1689–1692. https://doi.org/10.7314/apjcp.2014.15.4.1689

AFARI, M.E. and BHAT, T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Review of Cardiovascular Therapy. 2016, 14(5), 573–577. https://doi.org/10.1586/14779072.2016.1154788

AGRAWAL, N.K. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes. 2014, 5(5), 697. http://dx.doi.org/doi:10.4239/wjd.v5.i5.697

AMERICAN DIABETES ASSOCIATION. Introduction: Standards of medical care in diabetes - 2019. Diabetes Care. 2019, 42, S1–S2. http://dx.doi.org/doi:10.2337/dc19-Sint01

AZAB, B., et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Renal Failure. 2012, 34(5), 571–576. http://dx.doi.org/doi:10.3109/0886022X.2012.668741

DEMIRTAS, L., et al. Association of hematological indices with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015, 8(7), 11420–11427.

ERBAS, I.M., ET AL. Initial neutrophil/lymphocyte and lymphocyte/monocyte ratios can predict future insulin need in newly diagnosed type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2022, 18; 35(5): 593-602. https://doi.org/10.1515/jpem-2021-0564

ERIKSSON, A.K., et al. Work stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and women. Diabetes Care. 2013, 36(9), 2683–2689. http://dx.doi.org/doi:10.2337/dc12-1738

HERDER, C., CARSTENSEN, M. and OUWENS, D.M. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab. 2013, 15(3), 39–50. http://dx.doi.org/doi:10.1111/dom.12155

KAUTZKY-WILLER, A., HARREITER, J. and PACINI, G., Gender and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine Reviews. Endocrine Society. 2016, 37, 278–316. http://dx.doi.org/doi:10.1210/er.2015-1137

LANGSENLEHNER, T., et al. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy. Urol Oncol. 2015, 33(5), 201.e9-216.e9. http://dx.doi.org/doi:10.1016/j.urolonc.2015.02.002

LORENZO, C., HANLEY, A.J. and HAFFNER, S.M. Differential White cell count and incidence of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetologia. 2014, 57, 83-92. http://dx.doi.org/10.1007/s00125-013-3080-0

LOU, M., et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015, 15(9), 4–9. http://dx.doi.org/doi:10.1186/s12902-015-0002-9

MERTOĞLU, C. and GÜNAY, M. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Useful Predictive Markers of Prediabetes and Diabetes Mellitus. Diabetes Metab Syndr Clin Res Rev. 2016. http://dx.doi.org/10.1016/j.dsx.2016.12.021

MOGHANJOUGHI P. H. et al. Is the Neutrophil-to-Lymphocyte Ratio an Exceptional Indicator for Metabolic Syndrome Disease and Outcomes? Endocrine Practice. 2021, 28(3), 342-348. https://doi.org/10.1016/j.eprac.2021.11.083

NISHIMURA, S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009, 15, 914–920. http://dx.doi.org/doi:10.1038/nm.1964

PRATTICHIZZO, F., et al. Inflammageing and metaflammation: The yin and yang of type 2 diabetes. Vol. 41, Ageing Research Reviews. Elsevier Ireland Ltd; 2018. p. 1–17. http://dx.doi.org/doi:10.1016/j.arr.2017.10.003

RODACKI et al. Classificação do diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes. 2022. http://dx.doi.org/doi:10.29327/557753.2022-1

SHINY, A., et al. Association of Neutrophil-Lymphocyte Ratio with Glucose Intolerance: An Indicator of Systemic Inflammation in Patients with Type 2 Diabetes. Diabetes Technol Ther. 2014, 16(8), 524–530. http://dx.doi.org/doi:10.1089/dia.2013.0264

TABÁK, A.G., et al. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Enocrinol. 2010, 163, 89-95. http://dx.doi.org/doi:10.1530/EJE-10-0277

VON VIETINGHOFF, S. and LEY, K. Homeostatic regulation of blood neutrophil counts. J Immunol. 2008, 181, 5183-5188. http://dx.doi.org/doi:10.4049/jimmunol.181.8.5183

WHO. WORLD HEALTH ORGANIZATION. Global Report on Diabetes. 2016.

YINGLI LU et al. Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. J Diabetes Res. 2020, 2020, 1-9. https://doi.org/10.1155/2020/6219545

Zhang, C. et al. Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Their Dynamic Changes with Type 2 Diabetes Mellitus: A Cohort Study in China. Endocr Res. 2022, 47(3-4):138-152. https://doi.org/10.1080/07435800.2022.2127757